Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,328.40
+15.40 (1.17%)
Jan 28, 2026, 3:30 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.06 trillion as of January 28, 2026. Its market cap has decreased by -12.30% in one year.
Market Cap
1.06T
Enterprise Value
960.31B
Revenue
279.67B
Ranking
n/a
PE Ratio
23.34
Stock Price
1,328.40
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.06T, an increase of 69,966.92%. That is a compound annual growth rate of 24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.06T | -13.12% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3.92T |
| Divi's Laboratories | 1.60T |
| Zydus Lifesciences | 887.50B |
| Mankind Pharma | 870.03B |
| Alkem Laboratories | 687.56B |
| Aurobindo Pharma | 657.76B |
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |